A detailed history of Bank Of Montreal transactions in Natera, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 72,293 shares of NTRA stock, worth $9.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,293
Previous 45,678 58.27%
Holding current value
$9.09 Million
Previous $4.18 Million 87.41%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $2.27 Million - $3 Million
26,615 Added 58.27%
72,293 $7.83 Million
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $2.49 Million - $3.9 Million
41,979 Added 1134.87%
45,678 $4.18 Million
Q4 2023

Feb 08, 2024

SELL
$37.55 - $62.64 $61,431 - $102,479
-1,636 Reduced 30.67%
3,699 $231,000
Q3 2023

Nov 01, 2023

SELL
$43.4 - $62.52 $3.75 Million - $5.41 Million
-86,466 Reduced 94.19%
5,335 $236,000
Q2 2023

Aug 02, 2023

BUY
$47.08 - $55.16 $880,819 - $1.03 Million
18,709 Added 25.6%
91,801 $4.47 Million
Q1 2023

Jun 13, 2024

BUY
$36.57 - $58.29 $7.2 Million - $11.5 Million
196,881 Added 431.02%
242,559 $13.5 Million
Q4 2022

Feb 01, 2023

SELL
$34.17 - $47.91 $10.1 Million - $14.2 Million
-296,104 Reduced 80.2%
73,092 $2.94 Million
Q3 2022

Nov 10, 2022

SELL
$36.93 - $56.68 $245,843 - $377,318
-6,657 Reduced 1.77%
369,196 $18.7 Million
Q2 2022

Aug 11, 2022

BUY
$28.13 - $44.54 $6.91 Million - $10.9 Million
245,791 Added 188.98%
375,853 $15.1 Million
Q1 2022

May 12, 2022

BUY
$30.32 - $91.33 $1.76 Million - $5.3 Million
58,049 Added 80.61%
130,062 $5.39 Million
Q4 2021

Feb 11, 2022

SELL
$86.26 - $119.0 $243,166 - $335,461
-2,819 Reduced 3.77%
72,013 $6.8 Million
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $3.12 Million - $3.94 Million
31,182 Added 71.44%
74,832 $8.05 Million
Q2 2021

Aug 12, 2021

BUY
$86.05 - $119.72 $3.76 Million - $5.23 Million
43,650 New
43,650 $5.11 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.